We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

69 hedge funds and large institutions have $335M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q2 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.1%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$56.4M
2
VMI
VHCP Management II
New York
+$38.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
4
BlackRock
BlackRock
New York
+$23.5M
5
KCM
Knoll Capital Management
Florida
+$18.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$215K +$198K +8,592 New
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$196K +$180K +7,805 New
AIG
53
American International Group
New York
$155K +$143K +6,205 New
NFA
54
Nationwide Fund Advisors
Ohio
$143K +$132K +5,715 New
SO
55
STRS Ohio
Ohio
$72K +$66.8K +2,900 New
Legal & General Group
56
Legal & General Group
United Kingdom
$69K +$63.7K +2,768 New
NIT
57
NumerixS Investment Technologies
British Columbia, Canada
$60K +$55.3K +2,400 New
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$26.2K +$24.1K +1,048 New
Envestnet Asset Management
59
Envestnet Asset Management
Illinois
$25K +$22.8K +989 New
AIP
60
Ameritas Investment Partners
Nebraska
$22K +$20.2K +878 New
FPFS
61
First Personal Financial Services
North Carolina
$10K +$9.21K +400 New
CCA
62
Catalyst Capital Advisors
New York
$7K +$6.22K +270 New
PHK
63
Point72 Hong Kong
Hong Kong
$5K +$4.31K +187 New
MAM
64
Meeder Asset Management
Ohio
$4K +$3.25K +141 New
AG
65
Advisor Group
Arizona
$3K +$2.76K +120 New
Citigroup
66
Citigroup
New York
$2K +$1.54K +67 New
LTFS
67
Ladenburg Thalmann Financial Services
Florida
$1K +$760 +33 New
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
$1K +$921 +40 New
Barclays
69
Barclays
United Kingdom
– +$184 +8 New
1 2
3

BHVN Hedge Fund Activity: Q2 2017 in Review

69 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q2 2017, worth a combined $335M.

Buyers outnumbered sellers: 69 funds opened new BHVN positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $56.4M.

  • 69 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $335M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q2 2017.
  • 69 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q2 2017 and 0 closed out, a net change of +69 holders.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q2 2017 was RA Capital Management, an estimated $56.4M added.

Based on aggregated 13F filings for Q2 2017.